Maxime Sahun
4 Papers
Maxime Sahun is an academic researcher. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 2, co-authored 4 publications.
Chat about Author
Papers
Modulating the Antioxidant Response for Better Oxidative Stress-Inducing Therapies: How to Take Advantage of Two Sides of the Same Medal?
Priyanka Shaw,Naresh Kumar,Maxime Sahun,Evelien Smits,Annemie Bogaerts,Angela Privat-Maldonado +5 more
TL;DR: This review deals with the recent novel findings of various cellular endogenous antioxidant responses behind oxidative stress, highlighting their implication in various human diseases, such as ulcers, skin pathologies, oncology, and viral infections such as SARS-CoV-2.
Classification of red cell dynamics with convolutional and recurrent neural networks: a sickle cell disease case study
Maxime Darrin,Ashwin Samudre,Maxime Sahun,Scott X. Atwell,Catherine Badens,Anne Charrier,Emmanuèle Helfer,Annie Viallat,Vincent Cohen-Addad,Sophie Giffard-Roisin +9 more
TL;DR: In this paper , a two-stage end-to-end machine learning pipeline is presented to automatically classify cell motions in videos with a high class imbalance, using a convolutional neural network (CNN) model and a recurrent CNN.
Inactivation of SARS-CoV-2 and Other Enveloped and Non-Enveloped Viruses with Non-Thermal Plasma for Hospital Disinfection
Maxime Sahun,Angela Privat-Maldonado,Abraham Lin,Naomi De Roeck,Lisa Van der Heyden,Michael Hillen,Johan Michiels,Gunther Steenackers,Evelien Smits,Kevin K. Ariën,Philippe G. Jorens,Peter Delputte,Annemie Bogaerts +12 more
TL;DR: Wang et al. as mentioned in this paper demonstrated that 5 min treatment with a dielectric barrier discharge NTP can inactivate 100% of SARS-CoV-2 (Wuhan and Omicron strains) from plastic material.
Acquired non-thermal plasma resistance mediates a shift towards aerobic glycolysis and ferroptotic cell death in melanoma.
Abraham Lin,Maxime Sahun,Eline Biscop,Hanne Verswyvel,Jo De Waele,Joey De Backer,Claudia Theys,Bart Cuypers,Kris Laukens,Wim Vanden Berghe,Evelien Smits,Annemie Bogaerts +11 more
TL;DR: In this article , the authors used the first-ever NTP-resistant cell line derived from sensitive melanoma cells (A375), which was exposed to NTP and re-cultured for 12 consecutive weeks before evaluation against the parental control cells.